Selected research
Market Structure
Global Histamine H4 Receptor Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Histamine H4 Receptor market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Histamine H4 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Histamine H4 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Histamine H4 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Histamine H4 Receptor is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Histamine H4 Receptor include Johnson & Johnson, Ziarco Pharma Ltd, Sensorion S.A., Palau Pharma, S.A., OSE Pharma SA, Griffin Discoveries BV and Chrysalis Pharma SAS, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Histamine H4 Receptor market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Histamine H4 Receptor and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Histamine H4 Receptor sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Histamine H4 Receptor market size, projected growth trends, production technologies, key applications, and end-use industries.
Histamine H4 Receptor Segment by Company
Johnson & Johnson
Ziarco Pharma Ltd
Sensorion S.A.
Palau Pharma, S.A.
OSE Pharma SA
Griffin Discoveries BV
Chrysalis Pharma SAS
Histamine H4 Receptor Segment by Type
GD-48
JNJ-28307474
UR-63325
ZPL-389
Others
Histamine H4 Receptor Segment by Application
Cystic Fibrosis
Atopic Dermatitis
Hearing Disorders
Asthma
Others
Histamine H4 Receptor Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Histamine H4 Receptor market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Histamine H4 Receptor and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Histamine H4 Receptor.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Histamine H4 Receptor market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Histamine H4 Receptor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Histamine H4 Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Histamine H4 Receptor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- GD-48
- JNJ-28307474
- UR-63325
- ZPL-389
- Others
Applications
- Cystic Fibrosis
- Atopic Dermatitis
- Hearing Disorders
- Asthma
- Others
Companies covered
- Johnson & Johnson
- Ziarco Pharma Ltd
- Sensorion S.A.
- Palau Pharma, S.A.
- OSE Pharma SA
- Griffin Discoveries BV
- Chrysalis Pharma SAS
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Histamine H4 Receptor Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Histamine H4 Receptor Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Histamine H4 Receptor Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Histamine H4 Receptor Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Histamine H4 Receptor Market Dynamics
- 2.1 Histamine H4 Receptor Industry Trends
- 2.2 Histamine H4 Receptor Industry Drivers
- 2.3 Histamine H4 Receptor Industry Opportunities and Challenges
- 2.4 Histamine H4 Receptor Industry Restraints
3 Histamine H4 Receptor Market by Manufacturers
- 3.1 Global Histamine H4 Receptor Revenue by Manufacturers (2021-2026)
- 3.2 Global Histamine H4 Receptor Sales by Manufacturers (2021-2026)
- 3.3 Global Histamine H4 Receptor Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Histamine H4 Receptor Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Histamine H4 Receptor Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Histamine H4 Receptor Manufacturers, Product Type & Application
- 3.7 Global Histamine H4 Receptor Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Histamine H4 Receptor Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Histamine H4 Receptor Players Market Share by Revenue in 2025
- 3.8.3 2025 Histamine H4 Receptor Tier 1, Tier 2, and Tier 3
4 Histamine H4 Receptor Market by Type
- 4.1 Histamine H4 Receptor Type Introduction
- 4.1.1 GD-48
- 4.1.2 JNJ-28307474
- 4.1.3 UR-63325
- 4.1.4 ZPL-389
- 4.1.5 Others
- 4.2 Global Histamine H4 Receptor Sales by Type
- 4.2.1 Global Histamine H4 Receptor Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Histamine H4 Receptor Sales by Type (2021-2032)
- 4.2.3 Global Histamine H4 Receptor Sales Market Share by Type (2021-2032)
- 4.3 Global Histamine H4 Receptor Revenue by Type
- 4.3.1 Global Histamine H4 Receptor Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Histamine H4 Receptor Revenue by Type (2021-2032)
- 4.3.3 Global Histamine H4 Receptor Revenue Market Share by Type (2021-2032)
5 Histamine H4 Receptor Market by Application
- 5.1 Histamine H4 Receptor Application Introduction
- 5.1.1 Cystic Fibrosis
- 5.1.2 Atopic Dermatitis
- 5.1.3 Hearing Disorders
- 5.1.4 Asthma
- 5.1.5 Others
- 5.2 Global Histamine H4 Receptor Sales by Application
- 5.2.1 Global Histamine H4 Receptor Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Histamine H4 Receptor Sales by Application (2021-2032)
- 5.2.3 Global Histamine H4 Receptor Sales Market Share by Application (2021-2032)
- 5.3 Global Histamine H4 Receptor Revenue by Application
- 5.3.1 Global Histamine H4 Receptor Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Histamine H4 Receptor Revenue by Application (2021-2032)
- 5.3.3 Global Histamine H4 Receptor Revenue Market Share by Application (2021-2032)
6 Global Histamine H4 Receptor Sales by Region
- 6.1 Global Histamine H4 Receptor Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Histamine H4 Receptor Sales by Region (2021-2032)
- 6.2.1 Global Histamine H4 Receptor Sales by Region (2021-2026)
- 6.2.2 Global Histamine H4 Receptor Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Histamine H4 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Histamine H4 Receptor Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Histamine H4 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Histamine H4 Receptor Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Histamine H4 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Histamine H4 Receptor Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Histamine H4 Receptor Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Histamine H4 Receptor Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Histamine H4 Receptor Revenue by Region
- 7.1 Global Histamine H4 Receptor Revenue by Region
- 7.1.1 Global Histamine H4 Receptor Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Histamine H4 Receptor Revenue by Region (2021-2026)
- 7.1.3 Global Histamine H4 Receptor Revenue by Region (2027-2032)
- 7.1.4 Global Histamine H4 Receptor Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Histamine H4 Receptor Revenue (2021-2032)
- 7.2.2 North America Histamine H4 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Histamine H4 Receptor Revenue (2021-2032)
- 7.3.2 Europe Histamine H4 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Histamine H4 Receptor Revenue (2021-2032)
- 7.4.2 Asia-Pacific Histamine H4 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Histamine H4 Receptor Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Histamine H4 Receptor Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Johnson & Johnson
- 8.1.1 Johnson & Johnson Company Information
- 8.1.2 Johnson & Johnson Business Overview
- 8.1.3 Johnson & Johnson Histamine H4 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Johnson & Johnson Histamine H4 Receptor Product Portfolio
- 8.1.5 Johnson & Johnson Recent Developments
- 8.2 Ziarco Pharma Ltd
- 8.2.1 Ziarco Pharma Ltd Company Information
- 8.2.2 Ziarco Pharma Ltd Business Overview
- 8.2.3 Ziarco Pharma Ltd Histamine H4 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Ziarco Pharma Ltd Histamine H4 Receptor Product Portfolio
- 8.2.5 Ziarco Pharma Ltd Recent Developments
- 8.3 Sensorion S.A.
- 8.3.1 Sensorion S.A. Company Information
- 8.3.2 Sensorion S.A. Business Overview
- 8.3.3 Sensorion S.A. Histamine H4 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Sensorion S.A. Histamine H4 Receptor Product Portfolio
- 8.3.5 Sensorion S.A. Recent Developments
- 8.4 Palau Pharma, S.A.
- 8.4.1 Palau Pharma, S.A. Company Information
- 8.4.2 Palau Pharma, S.A. Business Overview
- 8.4.3 Palau Pharma, S.A. Histamine H4 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Palau Pharma, S.A. Histamine H4 Receptor Product Portfolio
- 8.4.5 Palau Pharma, S.A. Recent Developments
- 8.5 OSE Pharma SA
- 8.5.1 OSE Pharma SA Company Information
- 8.5.2 OSE Pharma SA Business Overview
- 8.5.3 OSE Pharma SA Histamine H4 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 OSE Pharma SA Histamine H4 Receptor Product Portfolio
- 8.5.5 OSE Pharma SA Recent Developments
- 8.6 Griffin Discoveries BV
- 8.6.1 Griffin Discoveries BV Company Information
- 8.6.2 Griffin Discoveries BV Business Overview
- 8.6.3 Griffin Discoveries BV Histamine H4 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Griffin Discoveries BV Histamine H4 Receptor Product Portfolio
- 8.6.5 Griffin Discoveries BV Recent Developments
- 8.7 Chrysalis Pharma SAS
- 8.7.1 Chrysalis Pharma SAS Company Information
- 8.7.2 Chrysalis Pharma SAS Business Overview
- 8.7.3 Chrysalis Pharma SAS Histamine H4 Receptor Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Chrysalis Pharma SAS Histamine H4 Receptor Product Portfolio
- 8.7.5 Chrysalis Pharma SAS Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Histamine H4 Receptor Value Chain Analysis
- 9.1.1 Histamine H4 Receptor Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Histamine H4 Receptor Production Mode & Process
- 9.2 Histamine H4 Receptor Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Histamine H4 Receptor Distributors
- 9.2.3 Histamine H4 Receptor Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst